101 related articles for article (PubMed ID: 15910884)
1. A second N-acylethanolamine hydrolase in mammalian tissues.
Ueda N; Tsuboi K; Lambert DM
Neuropharmacology; 2005 Jun; 48(8):1079-85. PubMed ID: 15910884
[TBL] [Abstract][Full Text] [Related]
2. N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.
Tsuboi K; Hilligsmann C; Vandevoorde S; Lambert DM; Ueda N
Biochem J; 2004 Apr; 379(Pt 1):99-106. PubMed ID: 14686878
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase.
Saturnino C; Petrosino S; Ligresti A; Palladino C; De Martino G; Bisogno T; Di Marzo V
Bioorg Med Chem Lett; 2010 Feb; 20(3):1210-3. PubMed ID: 20022504
[TBL] [Abstract][Full Text] [Related]
4. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
[TBL] [Abstract][Full Text] [Related]
5. The N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Tsuboi K; Takezaki N; Ueda N
Chem Biodivers; 2007 Aug; 4(8):1914-25. PubMed ID: 17712833
[TBL] [Abstract][Full Text] [Related]
6. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide.
Day TA; Rakhshan F; Deutsch DG; Barker EL
Mol Pharmacol; 2001 Jun; 59(6):1369-75. PubMed ID: 11353795
[TBL] [Abstract][Full Text] [Related]
7. An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors.
Ueda N; Yamanaka K; Terasawa Y; Yamamoto S
FEBS Lett; 1999 Jul; 454(3):267-70. PubMed ID: 10431820
[TBL] [Abstract][Full Text] [Related]
8. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance.
Ueda N; Yamanaka K; Yamamoto S
J Biol Chem; 2001 Sep; 276(38):35552-7. PubMed ID: 11463796
[TBL] [Abstract][Full Text] [Related]
10. Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase.
Fowler CJ; Börjesson M; Tiger G
Br J Pharmacol; 2000 Oct; 131(3):498-504. PubMed ID: 11015300
[TBL] [Abstract][Full Text] [Related]
11. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells.
Wang J; Zhao LY; Uyama T; Tsuboi K; Wu XX; Kakehi Y; Ueda N
J Biochem; 2008 Nov; 144(5):685-90. PubMed ID: 18806270
[TBL] [Abstract][Full Text] [Related]
12. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D
J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244
[TBL] [Abstract][Full Text] [Related]
13. High-throughput screening for the discovery of inhibitors of fatty acid amide hydrolase using a microsome-based fluorescent assay.
Wang Y; Ramirez F; Krishnamurthy G; Gilbert A; Kadakia N; Xu J; Kalgaonkar G; Ramarao MK; Edris W; Rogers KE; Jones PG
J Biomol Screen; 2006 Aug; 11(5):519-27. PubMed ID: 16760367
[TBL] [Abstract][Full Text] [Related]
14. A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison.
Labar G; Vliet FV; Wouters J; Lambert DM
Amino Acids; 2008 Jan; 34(1):127-33. PubMed ID: 17476568
[TBL] [Abstract][Full Text] [Related]
15. A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening.
Ramarao MK; Murphy EA; Shen MW; Wang Y; Bushell KN; Huang N; Pan N; Williams C; Clark JD
Anal Biochem; 2005 Aug; 343(1):143-51. PubMed ID: 16018870
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase.
Tsuboi K; Sun YX; Okamoto Y; Araki N; Tonai T; Ueda N
J Biol Chem; 2005 Mar; 280(12):11082-92. PubMed ID: 15655246
[TBL] [Abstract][Full Text] [Related]
17. A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening.
De Bank PA; Kendall DA; Alexander SP
Biochem Pharmacol; 2005 Apr; 69(8):1187-93. PubMed ID: 15794939
[TBL] [Abstract][Full Text] [Related]
18. Anandamide amidohydrolase (fatty acid amide hydrolase).
Ueda N; Yamamoto S
Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):19-28. PubMed ID: 10785539
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid amide hydrolase: from characterization to therapeutics.
Labar G; Michaux C
Chem Biodivers; 2007 Aug; 4(8):1882-902. PubMed ID: 17712824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]